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ABSTRACT: An automated approach to the collection of 1H NMR (nuclear magnetic resonance) spectra using a benchtop
NMR spectrometer and the subsequent analysis, processing, and elucidation of components present in seized drug samples are
reported. An algorithm is developed to compare spectral data to a reference library of over 300 1H NMR spectra, ranking
matches by a correlation-based score. A threshold for identiﬁcation was set at 0.838, below which identiﬁcation of the
component present was deemed unreliable. Using this system, 432 samples were surveyed and validated against
contemporaneously acquired GC−MS (gas chromatography−mass spectrometry) data. Following removal of samples which
possessed no peaks in the GC−MS trace or in both the 1H NMR spectrum and GC−MS trace, the remaining 416 samples
matched in 93% of cases. Thirteen of these samples were binary mixtures. A partial match (one component not identiﬁed) was
obtained for 6% of samples surveyed whilst only 1% of samples did not match at all.
■ INTRODUCTION
The detection, and identiﬁcation, of drugs within a seized
sample is a desirable means of evidence and intelligence
gathering.1 Given the growing issue of novel psychoactive
substances (NPS) and herbal products mixed with synthetic
cannabinoids, known as spice,2,3 a technique is required for the
detection of the active pharmaceutical ingredient (API) within
a seized sample, if indeed it is present. Such a technique is
urgently needed, given that the number of NPS reported to the
European Monitoring Centre for Drugs and Drug Addiction
(EMCDDA) has risen from 13 in 2008 to 101 in 20144 and
that in 2016, a survey of 625 UK inmates reported 33% had
used spice in the last month.5
The established analytical tools of GC−MS (gas chromatog-
raphy−mass spectrometry) and HPLC−MS (high perform-
ance liquid chromatography−MS), which are employed by
forensic laboratories (and by harm reduction point-of-care
services6) for the identiﬁcation and quantiﬁcation of drugs of
abuse, struggle with the high-throughput that is required to test
the number of seized samples. Additionally, in some instances,
the reference standards are not available for comparison.
Recently, a number of studies have been reported that focus on
the use of various spectroscopic techniques to achieve high
sample throughput, whilst also detecting the API present in
seized samples. Studies have utilized IR (infra-red) spectros-
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copy,7−10 Raman spectroscopy,11−14 NMR (nuclear magnetic
resonance),9,10,15−17 HPLC,9,10,18−21 and GC−MS.9,10,22−25
IR and Raman spectroscopies have been used for the
analysis of more than 200 seized NPS samples, resulting in the
identiﬁcation of a single component or a mixture in 76% of the
samples surveyed.26 17% of samples were partially identiﬁed,
with a further 7% that were unidentiﬁable. One of the
limitations of this study was the lack of reference spectra; the
reference library needed to be extended through the
independent identiﬁcation of NPS via NMR and MS.
A recent development concerning Raman spectroscopy is
the use of a portable hand-held technology for mobile
detection. A study employing 785 and 1064 nm excitation
sources highlighted that the latter wavelength was more
suitable, giving fewer false positives and false negatives for the
NPS screened whilst also signiﬁcantly lowering ﬂuorescence.27
In addition, IR has been used in conjunction with chemo-
metric methods (partial least squares (PLS) discriminant
analysis) to distinguish four classes of drugs with an average
reliability rate of 98.6% for the 932 samples surveyed.8 A
further use of PLS-based analysis in conjunction with Raman
and IR spectroscopies has been exempliﬁed for the
quantiﬁcation of cocaine in samples consisting of cocaine,
sodium carbonate, and either caﬀeine or lidocaine.28
A further study utilized liquid chromatography coupled to
high-resolution MS for the detection of NPS in wastewater
from a festival in Amsterdam.29 Implementation of an
algorithm to extract accurate masses which were then
compared to an in-house database of 2000 entries of NPS
and transformation products facilitated the detection of eight
NPS compounds.
The combination of dopant-assisted positive photoioniza-
tion ion mobility spectrometry (DAPP-IMS) and direct
analysis in real time time-of-ﬂight mass spectrometry
(DART-TOF MS) has been employed successfully to screen
drug samples with minimal sample preparation.30 Although the
method provided a fast response and high-throughput, the
method was limited due to its inability to identify all the
components in a mixture or unambiguously identify similar
compounds, such as epimers.
A method utilizing GC−MS for the analysis of cathinones,
amphetamine-like stimulants, and other NPS has been
developed that incorporates an almost simultaneous derivatiza-
tion and extraction step, which is achieved through the use of
hexyl chloroformate and dispersive liquid−liquid micro-
extraction.22 The chromatographic method allowed the
separation of 26 stimulants, which were all resolved in under
15 min.
The development of a compound database and HRMS
(high-resolution mass spectrometry) spectral library, consisting
of data for 875 and 252 NPS from multiple classes,
respectively, has been utilized for the analysis of 13 serum
samples that had been spiked with up to ﬁve NPS per
sample.31 32 of the 35 compounds present were detected using
the method developed. Furthermore, HRMS-based screening
of four seized samples provided results consistent with oﬃcial
forensic laboratory ﬁndings.
NMR, despite being a powerful analytical technique, has
been underutilized for the detection of drugs within samples.
This is largely because of the perceived complexity of the
measurement but also the inherent cost of requiring a
superconducting magnet and the associated technical costs.
However, the recent development of bench-top NMR
spectrometers has made this technique a much more attractive
and aﬀordable prospect. This approach is exempliﬁed through
the identiﬁcation of drugs in real case samples, carried out for
two samples, using a limited library of twelve spectra on a
benchtop 80 MHz spectrometer and compared by visual
inspection with data collected on a 600 MHz spectrometer.32
Another report has investigated the diﬀerentiation of 65
fentanyl analogues, by eye, using 1H NMR spectra obtained on
a low-ﬁeld spectrometer (62 MHz).33 Quantum mechanical
spin system analysis was employed in this report, and this
highlighted that ﬁeld strength-independent 1H NMR libraries
could be useful for drug analysis. Furthermore, the
quantiﬁcation of components in over-the-counter painkiller
drugs has been utilized in an undergraduate practical, again
using a visual inspection to identify the various components.16
Screening of spice samples using low-ﬁeld NMR has been
explored by Gilard and co-workers.34 In their study, nine
synthetic cannabinoids were detected and quantiﬁed. Although
high-ﬁeld NMR spectroscopy, sometimes in conjunction with
mass spectrometry, is required for unambiguous structural
identiﬁcation, low-ﬁeld NMR provided useful insights, in the
form of diagnostic signals, as to their chemical structure.
However, the greater spectral band overlap compared to data
acquired from a superconducting system did present a data
analysis challenge.
In this paper, we detail a fully automated NMR system that
acquires the 1H NMR spectrum of a sample, processes it, and
then using a developed pattern recognition algorithm,
compares the spectrum to a reference library of over 300 1H
NMR spectra, before ﬁnally reporting the drug(s) present (if
there are any to detect). The simplistic nature of the
experimental measurement overcomes the need for dedicated
technical staﬀ, and the robustness of the algorithm for spectral
analysis means that it can be readily utilized in custodial suites.
■ RESULTS AND DISCUSSION
Reference Library and Algorithm Development. 1H
NMR spectra of all reference compounds were collected using
the Pulsar instrument. The reference library thus consisted of
302 spectra altogether. The large number and types of
materials represented in the reference library enable a wide
range of seized materials to be identiﬁed and also allow for
various tests of the performance of the pattern recognition
algorithm.
The 1H NMR spectra were truncated into two discrete
sections: the “class” region (0.46−1.54 ppm) and a ﬁngerprint
region (3.90−12.50 ppm). “Classes” of compounds possess
similar backbone structures, and hence spectral features, but it
was imperative that the algorithm developed could also
diﬀerentiate compounds within a class. Both sections were
used in the pattern recognition process. Further, to account for
some variations in the dimethyl sulfoxide (DMSO) signal that
was used as an internal standard, the algorithm accommodated
a tolerance of ±0.06 ppm on the chemical shift of any peak.
Before commencing any analysis of seized samples, the
algorithm’s performance in terms of correct identiﬁcations was
tested by using it to the validation sample spectra. This allowed
evaluation of technical repeatability, as well as the ability of the
method to detect and identify previously unseen mixtures and
an estimation of the rate of false-positives.
Of the 130 controlled substance replicates, the class was
correctly identiﬁed in all but one of the samples (>99% success
rate) and the compound in all but six (>95% success rate).
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Notably, all of these were from the diphenidine class, of which
5 were misidentiﬁed as other closely related diphenidines.
Note that the diphenidines were somewhat over-represented
amongst the technical replicates due to the ready availability of
these compounds.
The algorithm produces a “match score” as an output for
each sample: this is the largest of the Pearson’s correlations
between the sample spectrum and each of the library spectra.
The median score from correct identiﬁcations across all classes
was 0.993. In contrast, the median score for the incorrect
identiﬁcations was 0.96. A summary ﬁgure expanding on these
values is given in the Supporting Information. It is worth
noting that the median score for the amphetamine class was
0.993 and that this was also the individual score for the
technical replicate of MDMA; this was the most prevalent
compound amongst the seized samples discussed below.
For the 32 validation mixtures, there were 21 correct
identiﬁcations of both compounds present in the sample. The
median match score for these was 0.923. This is substantially
lower than the typical match scores for single compounds,
reﬂecting the increased diﬃculty of identifying unknown
binary mixtures of unknown concentration ratios. A further
10 were identiﬁed as single compounds instead of mixtures,
with one of the two compounds being correctly identiﬁed. The
ﬁnal sample was found to be a mixture, but one of the
individual compounds was incorrectly identiﬁed as a diﬀerent
cutting agent; importantly, therefore, this was not a false
positive with regards to controlled substances. From
consideration of the outcomes from the validation samples, a
threshold was set empirically at 0.838: match scores greater
than this are indicative of a correct match, whereas
identiﬁcations with lower scores are considered unreliable.
Analysis of Seized Samples. 432 seized samples were
analyzed as part of this work. These samples represent a seized
material within the Greater Manchester region and tested by
the MANchester DRug Analysis & Knowledge Exchange
(MANDRAKE) partnership in accordance with the UK
Misuse of Drugs Act (1971) and Misuse of Drugs Regulations
(2001). All samples were analyzed using 1H NMR spectros-
copy (ca. 5−10 mg of sample dissolved in 0.6 mL of
deuterated DMSO) and GC−MS (see Supporting Information
for method and sample preparation). The results from the 1H
NMR analysis were cross-referenced with GC−MS data
acquired from the same sample. The GC−MS validation
approach is outlined in the Supporting Information. Com-
pounds identiﬁed through the work detailed herein are shown
in Figure 1.
Of the 432 samples analyzed, thirteen (3%) possessed no
peaks in the GC−MS chromatogram. Of these, 1H NMR
analysis identiﬁed that adulterants such as lactose were present,
which would require derivatization before they could be
detected by GC−MS. Two samples were identiﬁed as
containing lactose only (median match score 0.964) and
another one as sucrose only (match score 0.968). Two further
Figure 1. Compounds detected in the seized samples as part of this work.
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samples were indicated to be comprised of sodium gamma-
hydroxybutyric acid with a median match score of 0.851. The
other eight samples possessed match scores below the
identiﬁcation threshold (i.e. lower than 0.838), and thus
their identiﬁcations were considered unreliable.
Three samples returned a null result in both the 1H NMR
and GC−MS, that is, they consisted of no material that
possessed a 1H NMR signature, and no peak was observed in
the GC−MS trace.
The other 416 samples resulted in partial or complete
agreement between the 1H NMR and the GC−MS outcomes.
Of these 416 samples, the result from the 1H NMR analysis
matched the GC−MS result exactly in 387 cases (93%),
thirteen of which were identiﬁed as being binary mixtures by
both GC−MS and 1H NMR. Partial agreement was obtained
for 25 (6%) of samples surveyed, whilst the outcomes from just
4 samples (1%) did not match at all. A partial match here
means that either the 1H NMR analysis or the GC−MS trace
were missing one or more components than the other method
detected.
By far the most common drug identiﬁed was MDMA,
accounting for 171 instances (40% of samples surveyed).
Cocaine and ketamine (85 (20%) and 74 (17%) instances
respectively) were the next most common. Samples found to
contain mephedrone, paracetamol, benzocaine, ethylone,
heroin, caﬀeine, diazepam, or cannabis accounted for a further
23 samples (5% of samples surveyed). Figure 2 shows the
percentage breakdown by class of single and binary component
samples. A recent report from a UK festival onsite drug
checking service reported that the three most common drugs
identiﬁed were MDMA (57%), ketamine (13.5%), and cocaine
(10%).35 The results presented here reaﬃrm these drugs as the
most commonly encountered and with similar frequencies.
The median match score for the seized MDMA samples was
found to be 0.986 (range 0.858−0.997). This implies that
some of the samples analyzed were almost of reference
standard quality. In theory, an exact match with a reference
compound will have a score of 1; in practice, sources of
variance such as instrumental drift, spectral noise, and
concentration diﬀerences mean that this is rarely achieved.
The value obtained for the technical replicate of the reference
MDMA discussed above was 0.993. Figure 3 shows the 1H
NMR spectral variation of ten seized samples containing
MDMA in comparison to the 1H NMR reference spectrum of
MDMA.
Similarly, ketamine and cocaine samples had median match
scores of 0.980 and 0.973 respectively. For the cocaine
samples, the 1H NMR analysis was able to diﬀerentiate
between the free-base form and the hydrochloride salt. Four
instances of free-base cocaine were found, for which the
median match score was 0.184 higher than that of cocaine
hydrochloride (median match-score for free-base cocaine was
found to be 0.987). The diﬀerence between the two match
scores is important, as the match score for cocaine hydro-
chloride is below the validation threshold in some instances.
Although the 1H NMR spectroscopy analysis reveals this
diﬀerence, GC−MS only reports the presence of cocaine.
It is noteworthy that MDMA and ketamine both possess
amine protons and the 1H NMR chemical shift is
concentration-dependent (see Figure 3 for the variation of
the amine protons of MDMA at ca. δ 9.1). Thus, the algorithm
developed was able to successfully deal with this and still
match the 1H NMR spectrum to that of the reference
spectrum. The use of deuterated DMSO also prevents this
amine proton from being deuterated, and thus the molecule is
not needed to be chemically changed to facilitate its successful
detection. The median match scores for the other single
component samples are shown in Table 1.
The detection of 6-Br-MDMA in eight samples (two as the
sole component and six as a binary mixture with magnesium
stearate) highlights a way in which the method can be used to
identify a drug class, despite the material not being in the
reference library. Initial analysis of these eight samples
indicated that the material was a possible unknownall the
match scores were below the validation threshold as they
ranged from 0.755 to 0.644. Five samples reported the sample
consisting of an amphetamine (MDMA), whilst the other three
were indicated to be N-ethylpentylone hydrochloride, or a
precursor to its production, piperonal. Despite the range of
materials suggested, there is commonality, in that all of the
compounds possess a 1,2-methylenedioxybenzene ring, with
the benzene ring possessing a substituted aliphatic chain or
functional group. Analysis of the GC−MS traces for these eight
compounds identiﬁed a single component that had a retention
time of 6.7 min. Subsequent analysis of the samples using high-
ﬁeld 1H and 13C NMR spectroscopy and MS in conjunction
with previously reported36 MS data revealed the structure to be
6-Br-MDMA. A sample was synthesized and the reference
library updated accordingly with its 1H NMR spectrum. This
enabled two of the samples to be identiﬁed as 6-Br-MDMA
with a median match-score of 0.896, although a further
reference sample needed to be created to correctly identify the
Figure 2. Pie-chart showing the relative numbers of samples of
diﬀerent compositions, as identiﬁed by 1H NMR analysis and
subsequently validated by GC−MS, for (a) single component samples
and (b) binary mixtures.
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other six, due to the presence of magnesium stearate. These
samples are discussed further in the mixtures section.
The detection of diazepam in two samples required a
modiﬁcation of the general procedure to enable its analysis by
1H NMR spectroscopy. In general benzodiazepines such as
diazepam are produced as tablets which contain a large
concentration of lactose. When part of the tablet is dissolved in
DMSO both the API and excipient are soluble. The lactose is
in such a high concentration that it swamps the signals from
the diazepam. The subsequent result from matching the
ﬁngerprint is usually lactose. By contrast, the benzodiazepines
are soluble in acetonitrile while the lactose is practically
insoluble. Repeating the sample prep using deuterated
acetonitrile in place of DMSO-d6 allowing the
1H NMR data
acquisition and analysis to be performed under the same
conditions as the other samples analyzed. The corresponding
median match score for these two samples was 0.959. There
are other misused pharmaceuticals which may present a similar
issue with the analysis, for example, buprenorphine. The
procedure using deuterated acetonitrile is also applicable in
these cases.
Of the 416 samples exhibiting GC−MS peaks, 24 samples
were identiﬁed as synthetic cannabinoids, of which one was a
mixture. The synthetic cannabinoids needed extracting from
the plant material and were not seized as crystalline materials.
All of the samples were typically less than 1.5% API by weight
(see Supporting Information for details on the experimental
protocol used to determine this) with only three samples
possessing more than this threshold (highest 3.8%). Twenty
samples were found to comprise 5F-ADB as the sole API. We
note here that some of match scores for the samples were very
similar to other materials in the database. For example, four
samples had match scores that diﬀered by only 0.001−0.005
compared to that of buprenorphine hydrochloride whilst
another two samples were 0.003−0.008 diﬀerent to MMB-
CHMINACA. A further three samples were indicated to be 5F-
ADB by GC−MS but gave a null response in terms of the 1H
NMR analysis. The GC−MS traces for these three samples
indicated that the API was 0.3−0.7%. It is notable that of the
four samples that did not produce a match between the GC−
MS result and that of the 1H NMR analysis, three of them were
synthetic cannabinoid samples.
Mixtures. The algorithm developed is capable of detecting
binary mixtures, which is commonplace for drugs (e.g.
cocaine) as they are “cut” with another material. Of the
samples analyzed, thirteen samples were identiﬁed as being a
binary mixture by both GC−MS and 1H NMR, with a further
26 samples being identiﬁed as being a partial match, that is,
one component not identiﬁed in the 1H NMR spectrum when
two or more are present in the GC−MS trace, or vice versa.
Of the thirteen binary mixtures correctly identiﬁed, 69% of
these were cocaine based, the other 31% were amphetamine
and caﬀeine (two instances) and benzocaine and ketamine
(two instances). The cocaine samples were cut with caﬀeine,
Figure 3. Series of 1H NMR spectra of MDMA. Spectrum 1 is the reference spectrum that is included in the reference library, whereas spectra 2−
11 are seized samples (sample IDs 123, 207, 244, 309, 377, 405, 561B, 582, 598A, 598B, and 613).
Table 1. Median Match Scores for the Detection of Single
Component Mixtures (Inclusive of Null Responses)a
compound detected median match score
MDMA 0.986 (171)
6-Br-MDMA 0.896 (2)
ketamine 0.980 (74)
cocaine 0.973 (85)
benzocaine 0.960 (4)
mephedrone 0.909 (4)
paracetamol 0.939 (4)
ethylone 0.939 (2)
heroin 0.858 (3)
caﬀeine 0.855 (1)
diazepam 0.959 (2)
cannabis 0.937 (2)
5F-ADB 0.899 (20)
aThe number of samples identiﬁed of each type are indicated in
parentheses.
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levamisole, benzocaine, or phenacetin. Four samples were
identiﬁed as being a mixture of cocaine and levamisole by
GC−MS (retention times 8.22 and 7.50 min respectively) and
also by 1H NMR analysis (median match score 0.885).
Following analysis of the gas chromatogram, the amount of
levamisole in these samples was observed to range from 3.6 to
17.6%. The success of the 1H NMR analysis is particularly
noteworthy here, given that levamisole and cocaine have
similar aromatic moieties and therefore overlap in the 1H
NMR spectrum. The class region is key to distinguishing
between the two diﬀerent components in these cases, whilst
also facilitating the identiﬁcation of both components present.
One instance of a cocaine and phenacetin mixture was
identiﬁed by 1H NMR (match score 0.837) and validated by
the GC−MS data. Analysis of the gas chromatogram revealed
that cocaine was prevalent in this mixture (79.4% cocaine and
20.6% phenacetin). The relative amount of cocaine in the
single instance of cocaine mixed with caﬀeine was 90.2%. The
match score for this sample was 0.922. A similar median
match-score (0.849) was obtained for the two cocaine and
benzocaine samples despite the composition of cocaine varying
from 24.7 to 80.9%.
Two samples were identiﬁed as amphetamine and caﬀeine
(1H NMR median match score 0.890). From GC analysis, the
relative amount of amphetamine present ranged from 23.3 to
36.7%. Similarly, the two samples that returned ketamine and
benzocaine by both 1H NMR and GC−MS analysis had a 1H
NMR median match score of 0.919.
Partial Matches. 26 samples were identiﬁed as partial
matches. Six of these that contained 6-Br-MDMA, in its
hydrochloride form, were found to also consist of magnesium
stearate. In the absence of 6-Br-MDMA, magnesium stearate
does not dissolve in DMSO, as evidenced by the lack of peaks
in the 1H NMR spectrum. However, it was observed that if
magnesium stearate was added to a sample of 6-Br-MDMA
hydrochloride in DMSO, a new peak was observed at 1.21 ppm
in the 1H NMR spectrum with concomitant loss of the amine
peak at 9.23 ppm (see Supporting Information for 1H NMR
spectra). It is believed that a disproportionation reaction had
occurred, leading to the exchange of the chloride for stearate
which resulted in magnesium chloride being formed. The
practice of increasing the water solubility of drugs using
disproportionation is well-documented.37−40 Some samples
were more heavily cut with magnesium stearate than others,
and thus a reference 1H NMR spectrum of 6-Br-MDMA with
magnesium stearate was required. A suitable sample was
prepared, a 1H NMR spectrum acquired, and the reference
library was updated accordingly. Subsequently, the median
match score for the six seized samples was 0.926. These were
recorded as partial matches because magnesium stearate
cannot be observed under the GC−MS conditions employed
and so could not be validated.
Ten cocaine binary mixtures were recorded as partial
matches, with a further three that were found to be tertiary
mixtures and one that comprised six components. One of the
tertiary mixtures by GC−MS proved to comprise benzocaine,
paracetamol, and cocaine in a ratio of 6.6:15.8:77.6. The 1H
NMR analysis, which is limited to reporting on binary mixtures
only, returned paracetamol and cocaine as the match, with a
match score of 0.926. Benzocaine was not reported, most likely
due to the low concentration present in the sample. Similarly,
another tertiary mixture was identiﬁed to be cocaine,
benzocaine, and levamisole by GC−MS and returned cocaine
and benzocaine as the match in the 1H NMR analysis with a
match score of 0.869. As levamisole is only present at a level of
0.4%, it is not surprising that the 1H NMR analysis identiﬁed
the two most prevalent components. The ﬁnal tertiary mixture
was found to consist of cocaine, ketamine, and benzocaine in a
35.6:35.7:28.7 ratio. The match scores for benzocaine and
cocaine, and benzocaine and ketamine, diﬀer by only 0.007 for
this sample being 0.856 and 0.849, respectively. Thus, despite
the algorithm being limited to detecting two components only,
appraisal of the match scores can provide evidence for the
presence of three components in a mixture.
The six-component mixture consisted of cocaine, levamisole,
hexadecanoic acid, tolycaine, heptan-3-ol, and phenacetin with
cocaine (87.9%) and phenacetin (7.4%) being the most
prevalent. The 1H NMR analysis reported cocaine and
phenacetin with a match-score of 0.862. It is noteworthy
that the other components were all present at a level of 3% or
lower, and this will have hindered their detection in the 1H
NMR spectrum.
Of the ten cocaine binary mixtures, three samples did not
return cocaine as the primary identiﬁed API. All of these
samples comprised largely of benzocaine (>79%), and hence,
the 1H NMR spectrum was dominated by the signals of
benzocaine. Furthermore, the lower molecular weight of
benzocaine compared to cocaine results in lower signal
intensity of the latter in the 1H NMR spectrum, also hindering
its detection.
A further six samples were cocaine and levamisole binary
mixtures. For ﬁve of these samples, levamisole comprised <2%
of the sample according to GC−MS analysis (with one
exception where the levamisole was present at the 5% level),
and this might have prevented its detection in the 1H NMR
analysis. The other sample indicated levamisole as an
additional component in the 1H NMR analysis. Although
this represents a false-positive hit, the important aspect is that
cocaine is detected in the sample as this is the main API. The
ﬁnal cocaine containing sample was shown to be cut with
caﬀeine but only at the level of 1%. Again, this low amount is
not conducive to its detection by 1H NMR spectroscopy.
The remaining six samples were indicated by 1H NMR to
have one too few or one too many components compared to
the GC−MS trace. One of these samples returned only AMB-
FUBINACA by 1H NMR whilst the GC−MS showed it
comprised the former as well as 5F-ADB. Both components on
a weight-by-weight basis were <2.5%, with AMB-FUBINACA
being present at almost ﬁve times the amount of 5F-ADB.
Another sample was shown to comprise alpha-D-lactose and
caﬀeine whereas GC−MS reported only caﬀeine; this is as
expected, as lactose would need to be derivatized in order to be
detectable under the GC conditions employed. Another
sample of note here is one that comprised methiopropamine
and 2-aminoindane by GC−MS but was determined to be
methiopropamine and amphetamine sulfate following 1H
NMR analysis. Despite the diﬀerence in compositions, it
must be noted that 2-aminoindane is the rigid analogue of
amphetamine and hence has similar 1H NMR resonances; thus
there is a scientiﬁc rationale for its detection following 1H
NMR analysis.
■ CONCLUSIONS
There is a need for a high-throughput analytical technique with
facile sample preparation to deal with increasing numbers of
drug seizures made by law agencies. This paper presents an
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approach comprising an automated NMR benchtop spec-
trometer, which acquires, processes, and interprets the spectral
data with minimum user knowledge. The ﬁndings of the
analysis are reported in around 5 min.
The approach makes use of an algorithm that analyses the
acquired 1H NMR spectrum by matching it to a library of over
300 reference spectra from known substances. 432 seized
samples were tested using this system, and the outcomes
compared with GC−MS data, a currently accepted reference
method (see Table 2). The GC−MS trace in thirteen cases
(3% of the samples surveyed) were devoid of any peaks, so the
1H NMR analysis could not be validated for these samples. A
further three samples were found to lack any API or cutting
agent after both 1H NMR and GC−MS analysis.
For the remaining 416 samples, the outcomes by GC−MS
and 1H NMR matched in 93% of cases. Of these, thirteen
samples were identiﬁed as being a binary mixture by both
GC−MS and 1H NMR. A partial match (one component not
identiﬁed) was obtained for 6% of samples surveyed, whilst
only 1% of samples resulted in contradictory outcomes.
The analytical predictive power of the algorithm was
exempliﬁed in the detection of 6-Br-MDMA which identiﬁed
the methylenedioxy ring structure and the class of compound.
Further characterization of the samples, and the synthesis of a
reference sample, led to the complete elucidation of the
chemical structure. Note that the disproportionation of
chloride for stearate from magnesium stearate present in the
majority of seized samples of this type required an additional
reference 1H NMR spectrum to be acquired and the spectral
library updated accordingly. Eight samples were found to
possess 6-Br-MDMA as the API, with six of these being heavily
cut with magnesium stearate, as indicated by the match scores.
The protocol was modiﬁed for the detection of benzodia-
zepines, for example, diazepam. Deuterated acetonitrile was
used instead, but the methodology for detection, acquisition,
processing, and reporting remained consistent with that of the
samples collected in deuterated DMSO.
Having demonstrated the validity of the approach, future
work will be directed toward a quantiﬁcation method to widen
the applicability of the qualitative approach employed here,
and to improve the ability to handle multicomponent mixtures.
■ METHODOLOGY
Materials. 302 reference compounds were synthesized (see
below) or obtained either from Fluorochem (UK), Sigma
Aldrich (UK), BRC Fine Chemicals (https://www.brc-
ﬁnechemicals.com/prior to the UK Psychoactive Substances
Act (2016), which came in to eﬀect on the 26th May 2016 and
made it an oﬀence to manufacture, supply, possess, and import
and export psychoactive substances named in this Act) or
Carbosynth (UK). The following groups of chemicals were
synthesized according to, or adapted from, the literature
references cited: 4-methoxyamphetamines,41 2-, 3- and 4-
ﬂuoroamphetamines,42 thiopropamine,43 methiopropamine,44
dimethyldiphenidines,23 3- and 4-chloroethcathinone,45 tri-
ﬂuoromethylmethcathinones,45 3- and 4-chloro N,N-diethylca-
thinones,46 2-, 3- and 4-methcathinones,46 2-, 3- and 4-
ﬂuoromethcathinones,47 diphenidine and ephenidine deriva-
tives,23 fentanyl derivatives,48 ﬂuorolintanes,23 25I-,25B-, 25C-,
and 25F-NBOMe,49 MMB-CHMINACA, MMB-CHMICA,
5F-ADB, AMB-FUBINACA, and AB-FUBINACA,50 2C-C,
2C-B, 2C-I, 2C-F, and 2C-H.51 All synthesized reference
standards were fully characterized and exhibited physical and
spectral data consistent with the literature and determined to
be >99% pure by high-ﬁeld NMR. These consisted of a range
of narcotics, NPS, and controlled substances, as well as
commonly encountered non-controlled substances and adul-
terants. In total, there were 21 classes of compound:
aminoindanes, amphetamines, atypical diphenidines, benzo-
diazepines, cathinones, diphenidines, ephenidines, fentanyls,
ﬂuorolintanes, methylenedioxycathinones, NBOMe, narcotics,
pesticides, pharmaceuticals, phenethylamines, piperazines
(including MT-45 and its derivatives), precursors, steroids,
and synthetic cannabinoids. Two further “classes” of non-
controlled substances were also included: a range of “cutting
agents” and “background residues” (i.e., only DMSO).
432 seized samples of unknown identity were obtained from
Greater Manchester Police via the MANchester DRug Analysis
& Knowledge Ex-change (MANDRAKE) partnership and were
stored and analyzed in accordance with the UK Misuse of
Drugs Act (1971) and Misuse of Drugs Regulations (2001).
The samples were collected over the period January 2017−
August 2018. All of these samples were supplied in their solid,
bulk forms. For the seized materials, a micro-spatula tip of the
material (ca. 5−10 mg) was dissolved in 0.6 mL of deuterated
DMSO. If diazepam was suspected, then 0.6 mL of deuterated
acetonitrile was used instead. For spice samples, approximately
50 mg of material was weighed out and 0.6 mL of deuterated
DMSO added. The spice material was heavily agitated to
ensure that the API became dissolved in the DMSO. All
samples were ﬁltered through a 0.45 μm polyvinylidene
diﬂuoride syringe ﬁlter (Whatman) directly into a NMR tube.
Samples were analyzed by 1H NMR and validated against
contemporaneously acquired GC−MS data (GC−MS method
outlined in Supporting Information).
The reference samples were prepared for NMR analysis by
dissolving 10 mg of compound per 1 mL of deuterated DMSO,
or in the case of diazepam, deuterated MeCN.
130 compounds from the reference collection were available
in suﬃcient quantity to prepare a replicate sample. All but
three of the controlled substance classes (NBOMe, 2C-
derivatives and piperazines) were represented in this validation
collection. A further 32 samples of non-controlled substances
in the reference collection were prepared in pairwise
combinations, to assist with development of the mixture
identiﬁcation method.
NMR Data Acquisition. 1H NMR spectra were acquired of
all samples using a Pulsar benchtop NMR spectrometer
(Oxford Instruments, Abingdon, UK) operating at a frequency
of 59.7 MHz. The temperature of the probe was calculated to
be 308.5 K by measuring the separation (in Hz, Δδ) between
the CH2 and OH signals of neat ethylene glycol and
Table 2. Analysis Breakdown for the 432 Samples Surveyed
as Part of This Worka
no. of samples 432
% of samples that could not be validated 3.0 (13)
% samples found to contain no API or cutting agent 0.7 (3)
samples that do not match 0.9 (4)
% correctly matched (single component mixtures) 86.6 (374)
% correctly matched (two-component samples) 3.0 (13)
% partially matched (two or more component samples) 5.8 (25)
aThe number in parentheses indicate the number of samples of that
type.
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implementing the equation T [K] = 466.5 − 102.00Δδ.52 After
the sample had been inserted, an automated procedure began
whereby the instrument would lock on to the deuterated
signature of DMSO (thus used as a chemical shift reference)
before acquiring 16 scans (for the spice samples, 64 scans were
acquired).
Following acquisition, the data were processed in MNova
(Mestrelab Research, Santiago de Compostela, Spain) using an
automated script ﬁle. The processed FID was then analyzed by
the pattern recognition algorithm, developed in-house using
Matlab (The Mathworks Inc, Cambridge, UK). The algorithm
employs a minimum distance classiﬁer. The multivariate
distance between the sample spectrum and each of the
reference spectra is calculated. The sample is identiﬁed as the
nearest reference compound, provided the “match score”
(equal to one minus the distance) exceeds an (empirically
determined) threshold; if it does not, then the outcome is
considered to be tentative, unreliable, or unknown. Binary
mixtures are accommodated by extending the pattern search
with synthetically generated mixture spectra of pairwise
combinations of the reference library.
The collection of NMR data and the subsequent analysis
takes approximately 5 min. If signal-to-noise was found to be
poor, more scans were obtained. This was only required in less
than 1% of the samples being analyzed, and this was due to the
amount of sample available being low, for example, the residue
material within plastic packets used to transport illicit
materials.
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N.; Sena, M. M. Screening method for rapid classification of
psychoactive substances in illicit tablets using mid infrared spectros-
copy and PLS-DA. Forensic Sci. Int. 2018, 288, 227−235.
(9) McLaughlin, G.; Morris, N.; Kavanagh, P. V.; Power, J. D.;
O’Brien, J.; Talbot, B.; Elliott, S. P.; Wallach, J.; Hoang, K.; Morrish,
H.; Brandti, S. D. Test purchase, synthesis, and characterization of 2-
methoxydiphenidine (MXP) and differentiation from its meta- and
para-substituted isomers. Drug Test. Anal. 2016, 8, 98−109.
(10) Apirakkan, O.; Frinculescu, A.; Shine, T.; Parkin, M. C.;
Cilibrizzi, A.; Frascione, N.; Abbate, V. Analytical characterization of
three cathinone derivatives, 4-MPD, 4F-PHP and bk-EPDP,
purchased as bulk powder from online vendors. Drug Test. Anal.
2018, 10, 372−378.
(11) Fikiet, M. A.; Khandasammy, S. R.; Mistek, E.; Ahmed, Y.;
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